Comparative efficacy and tolerability of two sustained-release formulations of diclofenac: results of a double-blind, randomised study in patients with osteoarthritis and a reappraisal of diclofenac's use in this patient population

References

• Hunter DJ, Felson DT. Osteoarthritis. Br Med J 2006;332:639–42
   PubMed Web of Science ®Google Scholar
• Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Ann Rev Pharmacol Toxicol 1998;38: 97–120
   Google Scholar
• Kean WF, Buchanan WW. The use of NSAIDs in rheumatic disorders 2005: a global perspective. Inflammopharmacology 2005;13:343–70
   PubMedGoogle Scholar
• Mukherjee D, Topol EJ. Cox-2: where are we in 2003? – cardiovascular risk and Cox-2 inhibitors. Arthritis Res Ther 2003;5:8–11
   PubMed Web of Science ®Google Scholar
• Rodriguez LA, Patrignani P. The ever growing story of cyclooxygenase inhibition. Lancet 2006;368:1745–7
   PubMed Web of Science ®Google Scholar
• American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905–15
   PubMed Web of Science ®Google Scholar
• Jordan KM, Arden NK, Doherty M, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145–55
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005;64:669–81
   PubMed Web of Science ®Google Scholar
• Steinmeyer J, Konttinen YT. Oral treatment options for degenerative joint disease – present and future. Adv Drug Deliv Rev 2006;58:168–211
   PubMed Web of Science ®Google Scholar
• Langman MJ, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075–8
   PubMed Web of Science ®Google Scholar
• Altman R. International experience with diclofenac in osteoarthritis. Am J Med 1986;80(Suppl. 4B):48–52
   Google Scholar
• Ward JR. Efficacy of diclofenac in osteoarthritis. Experience in the United States. Am J Med 1986;80(Suppl. 4B):53–7
   Google Scholar
• Bakshi R. Comparative efficacy and tolerability of two diclofenac formulations in the treatment of painful osteoarthritis. Br J Clin Pract 1996;50:294–7
   PubMedGoogle Scholar
• Akhtar NM, Naseer R, Farooqi AZ et al. Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee – a double-blind prospective randomized study. Clin Rheumatol 2004;23:410–5
   PubMed Web of Science ®Google Scholar
• Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957;16:494–502
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24
   PubMed Web of Science ®Google Scholar
• Schattenkirchner M, Milachowski KA. A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain. Clin Rheumatol 2003;22:127–35
   PubMed Web of Science ®Google Scholar
• Zacher J, Feldman D, Gerli R, et al. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis. Curr Med Res Opin 2003;19:725–36
   PubMed Web of Science ®Google Scholar
• Le Loet X, Dreiser RL, Le Gros V, Febvre N. Therapeutic equivalence of diclofenac sustained-released 75 mg tablets and diclofenac enteric-coated 50 mg tablets in the treatment of painful osteoarthritis. Int J Clin Pract 1997;51:389–93
   PubMed Web of Science ®Google Scholar
• Schubiger BI, Ciccolunghi SN, Tanner K. Once daily dose treatment with a non-steroidal anti-rheumatic drug (diclofenac) in osteoarthrosis. J Int Med Res 1980;8:167–74
   Google Scholar
• Marenco JL, Perez M, Navarro FJ, et al. A multicentre, randomised, double-blind study to compare the efficacy and tolerability of dexketoprofen trometamol versus diclofenac in the symptomatic treatment of knee osteoarthritis. Clin Drug Investig 2000;19:247–56
   Web of Science ®Google Scholar
• Scheidel B, Blume H, Walter K, et al. Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation. Arzneimittelforschung/Drug Res 1993;43:1211–5
   Google Scholar
• Nishihata T, Sudho M, Kamada A, et al. Investigation of sustained-release suppository of sodium diclofenac in humans. Int J Pharm 1986;33:181–6
   Google Scholar
• Goei The HS, Lund B, Distel MR, Bluhmki E. A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 1997;5:283–8
   PubMed Web of Science ®Google Scholar
• Skeljo MV, Giraud AS, Yeomans ND. Gastric mucosal damage induced by nonsalicylate nonsteroidal antiinflammatory drugs in rats is mediated systemically. Dig Dis Sci 1993;38:2038–42
   Google Scholar
• Towheed T, Shea B, Wells G, Hochberg M. Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. Cochrane Database Syst Rev 2000;2:CD000517
   Google Scholar
• Bjordal JM, Ljunggren AE, Klovning A, Slordal L. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. Br Med J 2004;329:1317–20
   PubMed Web of Science ®Google Scholar
• NSAIDs for treating Osteoarthritis. Bandolier 1999; http://www.jr2.ox.ac.uk/bandolier/booth/painpag/Chronrev/OARA/OANSAID.html [accessed 18 December 2006]
   Google Scholar
• Deeks JJ, Smith LA, Bradley MD. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. Br Med J 2002;325:619–23
   Google Scholar
• Rostom A, Dube C, Jolicoeur E, et al. Gastroduodenal ulcers associated with the use of non-steroidal anti-inflammatory drugs: a systematic review of preventive pharmacological interventions. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 2004 [Technology overview 12]
   Google Scholar
• Spiegel BM, Chiou CF, Ofman JJ. Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups. Arthritis Rheum 2005;53:185–97
   Google Scholar
• Kearney PM, Baigent C, Godwin J, et al. Do selective cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. Br Med J 2006;332:1302–8
   PubMed Web of Science ®Google Scholar
• Solomon DH, Avorn J, Sturmer T, et al. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum 2006;54:1378–89
   PubMed Web of Science ®Google Scholar
• Watson MC, Brookes ST, Kirwan JR, Faulkner A. Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee. Cochrane Database Syst Rev 2000;2:CD000142
   Google Scholar
• Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000;43: 378–85
   Google Scholar
• Pincus T, Swearingen C, Cummins P, Callahan LF. Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis. J Rheumatol 2000;27:1020–7
   PubMed Web of Science ®Google Scholar
• Bannwarth B. Acetaminophen or NSAIDs for the treatment of osteoarthritis. Best Pract Res Clin Rheumatol 2006;20:117–29
   PubMed Web of Science ®Google Scholar
• Dougados M. Why and how to use NSAIDs in osteoarthritis. J Cardiovasc Pharmacol 2006;47(Suppl 1):S49–S54
   PubMedGoogle Scholar